Objectives To describe the humoral immune feature of patients with coronavirus disease
2019 (COVID-19). Methods The levels of total immunoglobulins (IgG, IgM, IgA, and IgE) …

Background Many COVID-19 patients reveal a marked decrease in their lymphocyte counts,
a condition that translates clinically into immunodepression and is common among these …

Background Crucial roles of hematologic and immunologic responses in progression of
coronavirus disease 2019 (COVID-19) remain largely unclear. Objective We sought to …

The description of a so-called cytokine storm in patients with COVID-19 has prompted
consideration of anti-cytokine therapies, particularly interleukin-6 antagonists. However …

Aim COVID-19 pandemic has caused extensive burden on public life and health care
worldwide. This study aimed to assess circulating levels of inflammatory cytokines in adult …

Background: Deficient interferon responses have been proposed as one of the relevant
mechanisms prompting severe manifestations of COVID-19. Objective: To evaluate the …

Abstract Coronavirus disease 2019 (COVID-19) is an emerging infectious disease caused
by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We investigated the …

Background Abnormalities of lymphocyte subsets and cytokine profiles have been observed
in most patients with coronavirus disease (COVID-19). Here, we explore the role of …

Aim To accumulate evidence that indicated the key role played by virus-triggered
inflammation in the 2019-novel coronavirus disease (COVID-19) which emerged in Wuhan …

Aims This study aimed to make a comparison between the clinical laboratory-related factors,
complete blood count (CBC) indices, cytokines, and lymphocyte subsets in order to …